nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Phentermine—obesity	0.161	0.292	CbGbCtD
Anagrelide—CYP1A2—Phenylpropanolamine—obesity	0.154	0.278	CbGbCtD
Anagrelide—CYP1A2—Bupropion—obesity	0.137	0.248	CbGbCtD
Anagrelide—CYP1A2—Cimetidine—obesity	0.101	0.182	CbGbCtD
Anagrelide—Ill-defined disorder—Sibutramine—obesity	0.000386	0.00113	CcSEcCtD
Anagrelide—Anaemia—Sibutramine—obesity	0.000385	0.00112	CcSEcCtD
Anagrelide—Osteoarthritis—Topiramate—obesity	0.000384	0.00112	CcSEcCtD
Anagrelide—Diplopia—Topiramate—obesity	0.000384	0.00112	CcSEcCtD
Anagrelide—Palpitations—Orlistat—obesity	0.00038	0.00111	CcSEcCtD
Anagrelide—Migraine—Topiramate—obesity	0.000378	0.0011	CcSEcCtD
Anagrelide—Nausea—Cimetidine—obesity	0.000378	0.0011	CcSEcCtD
Anagrelide—Mediastinal disorder—Bupropion—obesity	0.000376	0.00109	CcSEcCtD
Anagrelide—Malaise—Sibutramine—obesity	0.000375	0.00109	CcSEcCtD
Anagrelide—Cough—Orlistat—obesity	0.000375	0.00109	CcSEcCtD
Anagrelide—Chills—Bupropion—obesity	0.000374	0.00109	CcSEcCtD
Anagrelide—Syncope—Sibutramine—obesity	0.000373	0.00109	CcSEcCtD
Anagrelide—Convulsion—Orlistat—obesity	0.000373	0.00109	CcSEcCtD
Anagrelide—Arrhythmia—Bupropion—obesity	0.000372	0.00108	CcSEcCtD
Anagrelide—Alopecia—Bupropion—obesity	0.000368	0.00107	CcSEcCtD
Anagrelide—Palpitations—Sibutramine—obesity	0.000368	0.00107	CcSEcCtD
Anagrelide—Chest pain—Orlistat—obesity	0.000366	0.00107	CcSEcCtD
Anagrelide—Myalgia—Orlistat—obesity	0.000366	0.00107	CcSEcCtD
Anagrelide—Loss of consciousness—Sibutramine—obesity	0.000366	0.00107	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000364	0.00106	CcSEcCtD
Anagrelide—Cough—Sibutramine—obesity	0.000363	0.00106	CcSEcCtD
Anagrelide—Malnutrition—Bupropion—obesity	0.000363	0.00106	CcSEcCtD
Anagrelide—Discomfort—Orlistat—obesity	0.000362	0.00105	CcSEcCtD
Anagrelide—Convulsion—Sibutramine—obesity	0.000361	0.00105	CcSEcCtD
Anagrelide—Blood creatinine increased—Topiramate—obesity	0.00036	0.00105	CcSEcCtD
Anagrelide—Hypertension—Sibutramine—obesity	0.000359	0.00105	CcSEcCtD
Anagrelide—Dry mouth—Orlistat—obesity	0.000358	0.00104	CcSEcCtD
Anagrelide—Flatulence—Bupropion—obesity	0.000358	0.00104	CcSEcCtD
Anagrelide—Dehydration—Topiramate—obesity	0.000357	0.00104	CcSEcCtD
Anagrelide—Tension—Bupropion—obesity	0.000356	0.00104	CcSEcCtD
Anagrelide—Liver function test abnormal—Topiramate—obesity	0.000354	0.00103	CcSEcCtD
Anagrelide—Arthralgia—Sibutramine—obesity	0.000354	0.00103	CcSEcCtD
Anagrelide—Myalgia—Sibutramine—obesity	0.000354	0.00103	CcSEcCtD
Anagrelide—Chest pain—Sibutramine—obesity	0.000354	0.00103	CcSEcCtD
Anagrelide—Nervousness—Bupropion—obesity	0.000352	0.00103	CcSEcCtD
Anagrelide—Oedema—Orlistat—obesity	0.000351	0.00102	CcSEcCtD
Anagrelide—Back pain—Bupropion—obesity	0.000351	0.00102	CcSEcCtD
Anagrelide—Orthostatic hypotension—Topiramate—obesity	0.000351	0.00102	CcSEcCtD
Anagrelide—Discomfort—Sibutramine—obesity	0.00035	0.00102	CcSEcCtD
Anagrelide—Muscle spasms—Bupropion—obesity	0.000349	0.00102	CcSEcCtD
Anagrelide—Infection—Orlistat—obesity	0.000349	0.00102	CcSEcCtD
Anagrelide—Dry mouth—Sibutramine—obesity	0.000347	0.00101	CcSEcCtD
Anagrelide—Nervous system disorder—Orlistat—obesity	0.000344	0.001	CcSEcCtD
Anagrelide—Confusional state—Sibutramine—obesity	0.000343	0.000998	CcSEcCtD
Anagrelide—Vision blurred—Bupropion—obesity	0.000342	0.000996	CcSEcCtD
Anagrelide—Skin disorder—Orlistat—obesity	0.000341	0.000993	CcSEcCtD
Anagrelide—Gastritis—Topiramate—obesity	0.00034	0.00099	CcSEcCtD
Anagrelide—Oedema—Sibutramine—obesity	0.00034	0.00099	CcSEcCtD
Anagrelide—Hyperhidrosis—Orlistat—obesity	0.000339	0.000989	CcSEcCtD
Anagrelide—Infection—Sibutramine—obesity	0.000338	0.000983	CcSEcCtD
Anagrelide—Ill-defined disorder—Bupropion—obesity	0.000337	0.000981	CcSEcCtD
Anagrelide—Anaemia—Bupropion—obesity	0.000335	0.000977	CcSEcCtD
Anagrelide—Shock—Sibutramine—obesity	0.000334	0.000974	CcSEcCtD
Anagrelide—Thrombocytopenia—Sibutramine—obesity	0.000333	0.000969	CcSEcCtD
Anagrelide—Asthma—Topiramate—obesity	0.000332	0.000967	CcSEcCtD
Anagrelide—Dysphagia—Topiramate—obesity	0.000332	0.000967	CcSEcCtD
Anagrelide—Tachycardia—Sibutramine—obesity	0.000332	0.000966	CcSEcCtD
Anagrelide—Skin disorder—Sibutramine—obesity	0.00033	0.000961	CcSEcCtD
Anagrelide—Hyperhidrosis—Sibutramine—obesity	0.000328	0.000957	CcSEcCtD
Anagrelide—Malaise—Bupropion—obesity	0.000327	0.000953	CcSEcCtD
Anagrelide—Syncope—Bupropion—obesity	0.000325	0.000948	CcSEcCtD
Anagrelide—Pancreatitis—Topiramate—obesity	0.000325	0.000948	CcSEcCtD
Anagrelide—Anorexia—Sibutramine—obesity	0.000324	0.000943	CcSEcCtD
Anagrelide—Angina pectoris—Topiramate—obesity	0.000323	0.000942	CcSEcCtD
Anagrelide—Palpitations—Bupropion—obesity	0.000321	0.000934	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Orlistat—obesity	0.00032	0.000932	CcSEcCtD
Anagrelide—Bronchitis—Topiramate—obesity	0.000319	0.00093	CcSEcCtD
Anagrelide—Loss of consciousness—Bupropion—obesity	0.000319	0.000929	CcSEcCtD
Anagrelide—Abdominal discomfort—Topiramate—obesity	0.000318	0.000927	CcSEcCtD
Anagrelide—Insomnia—Orlistat—obesity	0.000318	0.000925	CcSEcCtD
Anagrelide—Hypotension—Sibutramine—obesity	0.000317	0.000925	CcSEcCtD
Anagrelide—Cough—Bupropion—obesity	0.000317	0.000923	CcSEcCtD
Anagrelide—Paraesthesia—Orlistat—obesity	0.000315	0.000918	CcSEcCtD
Anagrelide—Pancytopenia—Topiramate—obesity	0.000315	0.000918	CcSEcCtD
Anagrelide—Convulsion—Bupropion—obesity	0.000314	0.000916	CcSEcCtD
Anagrelide—Hypertension—Bupropion—obesity	0.000313	0.000913	CcSEcCtD
Anagrelide—Dysuria—Topiramate—obesity	0.00031	0.000904	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Sibutramine—obesity	0.00031	0.000902	CcSEcCtD
Anagrelide—Dyspepsia—Orlistat—obesity	0.000309	0.0009	CcSEcCtD
Anagrelide—Myalgia—Bupropion—obesity	0.000309	0.0009	CcSEcCtD
Anagrelide—Arthralgia—Bupropion—obesity	0.000309	0.0009	CcSEcCtD
Anagrelide—Chest pain—Bupropion—obesity	0.000309	0.0009	CcSEcCtD
Anagrelide—Insomnia—Sibutramine—obesity	0.000307	0.000895	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000307	0.000894	CcSEcCtD
Anagrelide—Pollakiuria—Topiramate—obesity	0.000307	0.000893	CcSEcCtD
Anagrelide—Erectile dysfunction—Topiramate—obesity	0.000306	0.00089	CcSEcCtD
Anagrelide—Discomfort—Bupropion—obesity	0.000305	0.000889	CcSEcCtD
Anagrelide—Decreased appetite—Orlistat—obesity	0.000305	0.000889	CcSEcCtD
Anagrelide—Paraesthesia—Sibutramine—obesity	0.000305	0.000889	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Orlistat—obesity	0.000303	0.000883	CcSEcCtD
Anagrelide—Dyspnoea—Sibutramine—obesity	0.000303	0.000882	CcSEcCtD
Anagrelide—Photosensitivity reaction—Topiramate—obesity	0.000303	0.000882	CcSEcCtD
Anagrelide—Fatigue—Orlistat—obesity	0.000303	0.000882	CcSEcCtD
Anagrelide—Dry mouth—Bupropion—obesity	0.000302	0.00088	CcSEcCtD
Anagrelide—Somnolence—Sibutramine—obesity	0.000302	0.00088	CcSEcCtD
Anagrelide—Weight increased—Topiramate—obesity	0.000302	0.00088	CcSEcCtD
Anagrelide—Weight decreased—Topiramate—obesity	0.0003	0.000875	CcSEcCtD
Anagrelide—Pain—Orlistat—obesity	0.0003	0.000875	CcSEcCtD
Anagrelide—Dyspepsia—Sibutramine—obesity	0.000299	0.000871	CcSEcCtD
Anagrelide—Confusional state—Bupropion—obesity	0.000299	0.00087	CcSEcCtD
Anagrelide—Pneumonia—Topiramate—obesity	0.000298	0.000867	CcSEcCtD
Anagrelide—Oedema—Bupropion—obesity	0.000296	0.000863	CcSEcCtD
Anagrelide—Decreased appetite—Sibutramine—obesity	0.000295	0.00086	CcSEcCtD
Anagrelide—Depression—Topiramate—obesity	0.000295	0.000859	CcSEcCtD
Anagrelide—Infection—Bupropion—obesity	0.000294	0.000857	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Sibutramine—obesity	0.000293	0.000854	CcSEcCtD
Anagrelide—Shock—Bupropion—obesity	0.000291	0.000849	CcSEcCtD
Anagrelide—Renal failure—Topiramate—obesity	0.000291	0.000847	CcSEcCtD
Anagrelide—Pain—Sibutramine—obesity	0.000291	0.000846	CcSEcCtD
Anagrelide—Constipation—Sibutramine—obesity	0.000291	0.000846	CcSEcCtD
Anagrelide—Nervous system disorder—Bupropion—obesity	0.00029	0.000846	CcSEcCtD
Anagrelide—Thrombocytopenia—Bupropion—obesity	0.00029	0.000845	CcSEcCtD
Anagrelide—Feeling abnormal—Orlistat—obesity	0.000289	0.000843	CcSEcCtD
Anagrelide—Tachycardia—Bupropion—obesity	0.000289	0.000842	CcSEcCtD
Anagrelide—Skin disorder—Bupropion—obesity	0.000288	0.000838	CcSEcCtD
Anagrelide—Urinary tract infection—Topiramate—obesity	0.000288	0.000838	CcSEcCtD
Anagrelide—Conjunctivitis—Topiramate—obesity	0.000288	0.000838	CcSEcCtD
Anagrelide—Gastrointestinal pain—Orlistat—obesity	0.000287	0.000836	CcSEcCtD
Anagrelide—Hyperhidrosis—Bupropion—obesity	0.000286	0.000834	CcSEcCtD
Anagrelide—Anorexia—Bupropion—obesity	0.000282	0.000822	CcSEcCtD
Anagrelide—Haematuria—Topiramate—obesity	0.000282	0.000822	CcSEcCtD
Anagrelide—Feeling abnormal—Sibutramine—obesity	0.00028	0.000816	CcSEcCtD
Anagrelide—Epistaxis—Topiramate—obesity	0.000279	0.000813	CcSEcCtD
Anagrelide—Urticaria—Orlistat—obesity	0.000279	0.000812	CcSEcCtD
Anagrelide—Gastrointestinal pain—Sibutramine—obesity	0.000278	0.000809	CcSEcCtD
Anagrelide—Sinusitis—Topiramate—obesity	0.000278	0.000809	CcSEcCtD
Anagrelide—Abdominal pain—Orlistat—obesity	0.000278	0.000808	CcSEcCtD
Anagrelide—Body temperature increased—Orlistat—obesity	0.000278	0.000808	CcSEcCtD
Anagrelide—Hypotension—Bupropion—obesity	0.000277	0.000806	CcSEcCtD
Anagrelide—Urticaria—Sibutramine—obesity	0.00027	0.000786	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Bupropion—obesity	0.00027	0.000786	CcSEcCtD
Anagrelide—Abdominal pain—Sibutramine—obesity	0.000269	0.000782	CcSEcCtD
Anagrelide—Body temperature increased—Sibutramine—obesity	0.000269	0.000782	CcSEcCtD
Anagrelide—Insomnia—Bupropion—obesity	0.000268	0.00078	CcSEcCtD
Anagrelide—Haemoglobin—Topiramate—obesity	0.000267	0.000778	CcSEcCtD
Anagrelide—Rhinitis—Topiramate—obesity	0.000266	0.000776	CcSEcCtD
Anagrelide—Paraesthesia—Bupropion—obesity	0.000266	0.000775	CcSEcCtD
Anagrelide—Haemorrhage—Topiramate—obesity	0.000266	0.000774	CcSEcCtD
Anagrelide—Hepatitis—Topiramate—obesity	0.000266	0.000774	CcSEcCtD
Anagrelide—Hypoaesthesia—Topiramate—obesity	0.000264	0.00077	CcSEcCtD
Anagrelide—Dyspnoea—Bupropion—obesity	0.000264	0.000769	CcSEcCtD
Anagrelide—Pharyngitis—Topiramate—obesity	0.000264	0.000768	CcSEcCtD
Anagrelide—Somnolence—Bupropion—obesity	0.000263	0.000767	CcSEcCtD
Anagrelide—Urinary tract disorder—Topiramate—obesity	0.000262	0.000764	CcSEcCtD
Anagrelide—Oedema peripheral—Topiramate—obesity	0.000262	0.000762	CcSEcCtD
Anagrelide—Connective tissue disorder—Topiramate—obesity	0.000261	0.00076	CcSEcCtD
Anagrelide—Dyspepsia—Bupropion—obesity	0.000261	0.000759	CcSEcCtD
Anagrelide—Urethral disorder—Topiramate—obesity	0.00026	0.000758	CcSEcCtD
Anagrelide—Decreased appetite—Bupropion—obesity	0.000257	0.00075	CcSEcCtD
Anagrelide—Visual impairment—Topiramate—obesity	0.000256	0.000746	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Bupropion—obesity	0.000256	0.000745	CcSEcCtD
Anagrelide—Fatigue—Bupropion—obesity	0.000255	0.000744	CcSEcCtD
Anagrelide—Pain—Bupropion—obesity	0.000253	0.000738	CcSEcCtD
Anagrelide—Constipation—Bupropion—obesity	0.000253	0.000738	CcSEcCtD
Anagrelide—Asthenia—Orlistat—obesity	0.000252	0.000734	CcSEcCtD
Anagrelide—Pruritus—Orlistat—obesity	0.000248	0.000724	CcSEcCtD
Anagrelide—Eye disorder—Topiramate—obesity	0.000248	0.000723	CcSEcCtD
Anagrelide—Tinnitus—Topiramate—obesity	0.000248	0.000721	CcSEcCtD
Anagrelide—Cardiac disorder—Topiramate—obesity	0.000246	0.000718	CcSEcCtD
Anagrelide—Feeling abnormal—Bupropion—obesity	0.000244	0.000711	CcSEcCtD
Anagrelide—Asthenia—Sibutramine—obesity	0.000244	0.00071	CcSEcCtD
Anagrelide—Gastrointestinal pain—Bupropion—obesity	0.000242	0.000706	CcSEcCtD
Anagrelide—Pruritus—Sibutramine—obesity	0.00024	0.0007	CcSEcCtD
Anagrelide—Diarrhoea—Orlistat—obesity	0.00024	0.0007	CcSEcCtD
Anagrelide—Mediastinal disorder—Topiramate—obesity	0.000239	0.000697	CcSEcCtD
Anagrelide—Chills—Topiramate—obesity	0.000238	0.000694	CcSEcCtD
Anagrelide—Urticaria—Bupropion—obesity	0.000235	0.000685	CcSEcCtD
Anagrelide—Alopecia—Topiramate—obesity	0.000235	0.000684	CcSEcCtD
Anagrelide—Abdominal pain—Bupropion—obesity	0.000234	0.000682	CcSEcCtD
Anagrelide—Body temperature increased—Bupropion—obesity	0.000234	0.000682	CcSEcCtD
Anagrelide—Diarrhoea—Sibutramine—obesity	0.000232	0.000677	CcSEcCtD
Anagrelide—Dizziness—Orlistat—obesity	0.000232	0.000676	CcSEcCtD
Anagrelide—Malnutrition—Topiramate—obesity	0.000231	0.000674	CcSEcCtD
Anagrelide—Flatulence—Topiramate—obesity	0.000228	0.000664	CcSEcCtD
Anagrelide—Tension—Topiramate—obesity	0.000227	0.000661	CcSEcCtD
Anagrelide—Dizziness—Sibutramine—obesity	0.000225	0.000654	CcSEcCtD
Anagrelide—Nervousness—Topiramate—obesity	0.000225	0.000654	CcSEcCtD
Anagrelide—Back pain—Topiramate—obesity	0.000224	0.000652	CcSEcCtD
Anagrelide—Vomiting—Orlistat—obesity	0.000223	0.00065	CcSEcCtD
Anagrelide—Muscle spasms—Topiramate—obesity	0.000222	0.000648	CcSEcCtD
Anagrelide—Rash—Orlistat—obesity	0.000221	0.000645	CcSEcCtD
Anagrelide—Dermatitis—Orlistat—obesity	0.000221	0.000644	CcSEcCtD
Anagrelide—Headache—Orlistat—obesity	0.00022	0.000641	CcSEcCtD
Anagrelide—Vision blurred—Topiramate—obesity	0.000218	0.000635	CcSEcCtD
Anagrelide—Vomiting—Sibutramine—obesity	0.000216	0.000629	CcSEcCtD
Anagrelide—Ill-defined disorder—Topiramate—obesity	0.000215	0.000625	CcSEcCtD
Anagrelide—Rash—Sibutramine—obesity	0.000214	0.000624	CcSEcCtD
Anagrelide—Dermatitis—Sibutramine—obesity	0.000214	0.000623	CcSEcCtD
Anagrelide—Anaemia—Topiramate—obesity	0.000214	0.000623	CcSEcCtD
Anagrelide—Headache—Sibutramine—obesity	0.000213	0.00062	CcSEcCtD
Anagrelide—Asthenia—Bupropion—obesity	0.000212	0.000619	CcSEcCtD
Anagrelide—Pruritus—Bupropion—obesity	0.00021	0.00061	CcSEcCtD
Anagrelide—Nausea—Orlistat—obesity	0.000209	0.000607	CcSEcCtD
Anagrelide—Malaise—Topiramate—obesity	0.000208	0.000607	CcSEcCtD
Anagrelide—Syncope—Topiramate—obesity	0.000207	0.000604	CcSEcCtD
Anagrelide—Palpitations—Topiramate—obesity	0.000204	0.000595	CcSEcCtD
Anagrelide—Loss of consciousness—Topiramate—obesity	0.000203	0.000592	CcSEcCtD
Anagrelide—Diarrhoea—Bupropion—obesity	0.000203	0.00059	CcSEcCtD
Anagrelide—Nausea—Sibutramine—obesity	0.000202	0.000588	CcSEcCtD
Anagrelide—Cough—Topiramate—obesity	0.000202	0.000588	CcSEcCtD
Anagrelide—Convulsion—Topiramate—obesity	0.0002	0.000584	CcSEcCtD
Anagrelide—Hypertension—Topiramate—obesity	0.0002	0.000582	CcSEcCtD
Anagrelide—Arthralgia—Topiramate—obesity	0.000197	0.000573	CcSEcCtD
Anagrelide—Myalgia—Topiramate—obesity	0.000197	0.000573	CcSEcCtD
Anagrelide—Chest pain—Topiramate—obesity	0.000197	0.000573	CcSEcCtD
Anagrelide—Dizziness—Bupropion—obesity	0.000196	0.000571	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000195	0.000569	CcSEcCtD
Anagrelide—Discomfort—Topiramate—obesity	0.000194	0.000567	CcSEcCtD
Anagrelide—Dry mouth—Topiramate—obesity	0.000193	0.000561	CcSEcCtD
Anagrelide—Confusional state—Topiramate—obesity	0.00019	0.000554	CcSEcCtD
Anagrelide—Oedema—Topiramate—obesity	0.000189	0.00055	CcSEcCtD
Anagrelide—Vomiting—Bupropion—obesity	0.000188	0.000549	CcSEcCtD
Anagrelide—Infection—Topiramate—obesity	0.000187	0.000546	CcSEcCtD
Anagrelide—Rash—Bupropion—obesity	0.000187	0.000544	CcSEcCtD
Anagrelide—Dermatitis—Bupropion—obesity	0.000187	0.000544	CcSEcCtD
Anagrelide—Shock—Topiramate—obesity	0.000186	0.000541	CcSEcCtD
Anagrelide—Headache—Bupropion—obesity	0.000186	0.000541	CcSEcCtD
Anagrelide—Nervous system disorder—Topiramate—obesity	0.000185	0.000539	CcSEcCtD
Anagrelide—Thrombocytopenia—Topiramate—obesity	0.000185	0.000538	CcSEcCtD
Anagrelide—Tachycardia—Topiramate—obesity	0.000184	0.000536	CcSEcCtD
Anagrelide—Skin disorder—Topiramate—obesity	0.000183	0.000534	CcSEcCtD
Anagrelide—Hyperhidrosis—Topiramate—obesity	0.000182	0.000531	CcSEcCtD
Anagrelide—Anorexia—Topiramate—obesity	0.00018	0.000524	CcSEcCtD
Anagrelide—Hypotension—Topiramate—obesity	0.000176	0.000514	CcSEcCtD
Anagrelide—Nausea—Bupropion—obesity	0.000176	0.000512	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Topiramate—obesity	0.000172	0.000501	CcSEcCtD
Anagrelide—Insomnia—Topiramate—obesity	0.000171	0.000497	CcSEcCtD
Anagrelide—Paraesthesia—Topiramate—obesity	0.000169	0.000494	CcSEcCtD
Anagrelide—Dyspnoea—Topiramate—obesity	0.000168	0.00049	CcSEcCtD
Anagrelide—Somnolence—Topiramate—obesity	0.000168	0.000489	CcSEcCtD
Anagrelide—Dyspepsia—Topiramate—obesity	0.000166	0.000484	CcSEcCtD
Anagrelide—Decreased appetite—Topiramate—obesity	0.000164	0.000478	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Topiramate—obesity	0.000163	0.000475	CcSEcCtD
Anagrelide—Fatigue—Topiramate—obesity	0.000163	0.000474	CcSEcCtD
Anagrelide—Pain—Topiramate—obesity	0.000161	0.00047	CcSEcCtD
Anagrelide—Constipation—Topiramate—obesity	0.000161	0.00047	CcSEcCtD
Anagrelide—Feeling abnormal—Topiramate—obesity	0.000155	0.000453	CcSEcCtD
Anagrelide—Gastrointestinal pain—Topiramate—obesity	0.000154	0.000449	CcSEcCtD
Anagrelide—Urticaria—Topiramate—obesity	0.00015	0.000437	CcSEcCtD
Anagrelide—Body temperature increased—Topiramate—obesity	0.000149	0.000435	CcSEcCtD
Anagrelide—Abdominal pain—Topiramate—obesity	0.000149	0.000435	CcSEcCtD
Anagrelide—Asthenia—Topiramate—obesity	0.000135	0.000394	CcSEcCtD
Anagrelide—Pruritus—Topiramate—obesity	0.000134	0.000389	CcSEcCtD
Anagrelide—Diarrhoea—Topiramate—obesity	0.000129	0.000376	CcSEcCtD
Anagrelide—Dizziness—Topiramate—obesity	0.000125	0.000364	CcSEcCtD
Anagrelide—Vomiting—Topiramate—obesity	0.00012	0.00035	CcSEcCtD
Anagrelide—Rash—Topiramate—obesity	0.000119	0.000347	CcSEcCtD
Anagrelide—Dermatitis—Topiramate—obesity	0.000119	0.000346	CcSEcCtD
Anagrelide—Headache—Topiramate—obesity	0.000118	0.000344	CcSEcCtD
Anagrelide—Nausea—Topiramate—obesity	0.000112	0.000327	CcSEcCtD
Anagrelide—PDE3A—Signaling Pathways—PARP1—obesity	6.57e-05	0.000635	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GHRL—obesity	6.57e-05	0.000635	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD4—obesity	6.52e-05	0.00063	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GLRX—obesity	6.49e-05	0.000627	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—obesity	6.34e-05	0.000613	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—obesity	6.34e-05	0.000613	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—POMC—obesity	6.33e-05	0.000612	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—F2—obesity	6.31e-05	0.00061	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PRKCB—obesity	6.31e-05	0.00061	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CNR1—obesity	6.23e-05	0.000602	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ACSL1—obesity	6.14e-05	0.000593	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1B—obesity	6.14e-05	0.000593	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—obesity	6.14e-05	0.000593	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TCF7L2—obesity	6.12e-05	0.000591	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—AKT2—obesity	6.09e-05	0.000588	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD2—obesity	6.07e-05	0.000587	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PIK3CG—obesity	6.04e-05	0.000584	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PTPN1—obesity	6.01e-05	0.000581	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GCG—obesity	6.01e-05	0.000581	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—HADH—obesity	5.96e-05	0.000576	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—obesity	5.96e-05	0.000576	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PIK3CD—obesity	5.85e-05	0.000565	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PPM1L—obesity	5.78e-05	0.000559	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—OTC—obesity	5.78e-05	0.000559	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ETFDH—obesity	5.78e-05	0.000559	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—INSIG2—obesity	5.78e-05	0.000559	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—TGFB1—obesity	5.78e-05	0.000558	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—POMC—obesity	5.75e-05	0.000556	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRL—obesity	5.74e-05	0.000554	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—STK11—obesity	5.65e-05	0.000546	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCL2—obesity	5.63e-05	0.000544	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PLG—obesity	5.59e-05	0.00054	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—obesity	5.58e-05	0.000539	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—RHOA—obesity	5.58e-05	0.000539	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—AKT2—obesity	5.53e-05	0.000534	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PIK3R1—obesity	5.52e-05	0.000534	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—FOXO3—obesity	5.46e-05	0.000527	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ADRB2—obesity	5.44e-05	0.000526	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LPA—obesity	5.39e-05	0.000521	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SOCS1—obesity	5.36e-05	0.000518	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PIK3CD—obesity	5.31e-05	0.000513	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SOCS3—obesity	5.29e-05	0.000512	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GPT—obesity	5.29e-05	0.000511	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—UQCRC2—obesity	5.29e-05	0.000511	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—INPP5E—obesity	5.29e-05	0.000511	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LPIN1—obesity	5.28e-05	0.00051	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GNB3—obesity	5.18e-05	0.000501	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—obesity	5.17e-05	0.000499	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—TYK2—obesity	5.11e-05	0.000494	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PIK3CB—obesity	5.1e-05	0.000493	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IGF2—obesity	5.09e-05	0.000492	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—RHOA—obesity	5.07e-05	0.00049	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GNAS—obesity	5.05e-05	0.000488	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PIK3R1—obesity	5.02e-05	0.000485	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—APOB—obesity	4.94e-05	0.000477	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—obesity	4.93e-05	0.000476	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PIK3CA—obesity	4.92e-05	0.000475	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ALDH6A1—obesity	4.92e-05	0.000475	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ME1—obesity	4.92e-05	0.000475	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SUCLG2—obesity	4.92e-05	0.000475	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—POMC—obesity	4.9e-05	0.000474	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL5—obesity	4.83e-05	0.000466	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—obesity	4.8e-05	0.000464	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—LPL—obesity	4.72e-05	0.000456	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—FOXO1—obesity	4.68e-05	0.000453	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—RPS6KB1—obesity	4.68e-05	0.000452	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PIK3CB—obesity	4.63e-05	0.000447	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—COX7C—obesity	4.62e-05	0.000447	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PNPLA3—obesity	4.62e-05	0.000447	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—UCP1—obesity	4.62e-05	0.000447	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—obesity	4.39e-05	0.000425	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DGAT2—obesity	4.38e-05	0.000423	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CS—obesity	4.38e-05	0.000423	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SUCLA2—obesity	4.38e-05	0.000423	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CPS1—obesity	4.38e-05	0.000423	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRKCD—obesity	4.35e-05	0.00042	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—obesity	4.28e-05	0.000414	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—obesity	4.26e-05	0.000411	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR2A—obesity	4.25e-05	0.000411	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—C3—obesity	4.25e-05	0.00041	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LIPE—obesity	4.18e-05	0.000404	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MUT—obesity	4.18e-05	0.000404	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—obesity	4.13e-05	0.000399	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—obesity	4.09e-05	0.000395	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IRS2—obesity	4.04e-05	0.000391	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—AGT—obesity	4.04e-05	0.00039	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—obesity	4.02e-05	0.000388	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—AKT1—obesity	4.02e-05	0.000388	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DGAT1—obesity	4.01e-05	0.000387	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYB5A—obesity	4.01e-05	0.000387	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—obesity	3.96e-05	0.000382	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—LEP—obesity	3.95e-05	0.000382	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—APOE—obesity	3.95e-05	0.000382	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CAV1—obesity	3.92e-05	0.000379	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—APOA1—obesity	3.91e-05	0.000378	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACLY—obesity	3.86e-05	0.000373	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—obesity	3.84e-05	0.000371	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ESR1—obesity	3.78e-05	0.000365	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRKCB—obesity	3.73e-05	0.00036	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—F2—obesity	3.73e-05	0.00036	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ALOX12—obesity	3.73e-05	0.00036	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ENPP1—obesity	3.73e-05	0.00036	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—BAD—obesity	3.69e-05	0.000356	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—obesity	3.66e-05	0.000353	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—obesity	3.64e-05	0.000352	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—HMGCS1—obesity	3.61e-05	0.000349	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PIK3CG—obesity	3.57e-05	0.000345	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IRS1—obesity	3.53e-05	0.000341	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACADM—obesity	3.5e-05	0.000338	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SAT1—obesity	3.5e-05	0.000338	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PNPLA2—obesity	3.5e-05	0.000338	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ANGPTL4—obesity	3.5e-05	0.000338	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PFKFB3—obesity	3.5e-05	0.000338	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PLIN1—obesity	3.5e-05	0.000338	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACACB—obesity	3.41e-05	0.000329	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYTB—obesity	3.41e-05	0.000329	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—OXCT1—obesity	3.41e-05	0.000329	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—POMC—obesity	3.4e-05	0.000328	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—INS—obesity	3.38e-05	0.000326	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL2—obesity	3.32e-05	0.000321	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SRD5A1—obesity	3.32e-05	0.000321	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PNLIP—obesity	3.32e-05	0.000321	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IGF1—obesity	3.27e-05	0.000316	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—AKT2—obesity	3.27e-05	0.000316	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SDC3—obesity	3.24e-05	0.000313	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—obesity	3.23e-05	0.000312	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—obesity	3.18e-05	0.000307	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP26B1—obesity	3.17e-05	0.000306	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—STS—obesity	3.17e-05	0.000306	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—HK2—obesity	3.17e-05	0.000306	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PIK3CD—obesity	3.14e-05	0.000303	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—obesity	3.13e-05	0.000303	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PIK3CA—obesity	3.11e-05	0.0003	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SERPINE1—obesity	3.1e-05	0.0003	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PPARD—obesity	3.1e-05	0.0003	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC27A1—obesity	3.04e-05	0.000293	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TYK2—obesity	3.02e-05	0.000292	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—RHOA—obesity	2.99e-05	0.000289	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—FABP4—obesity	2.98e-05	0.000288	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GLUL—obesity	2.98e-05	0.000288	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PIK3R1—obesity	2.96e-05	0.000286	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NOS3—obesity	2.96e-05	0.000286	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	2.87e-05	0.000277	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—UCP3—obesity	2.82e-05	0.000273	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ECHS1—obesity	2.82e-05	0.000273	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—HSD11B1—obesity	2.82e-05	0.000273	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—UCP2—obesity	2.82e-05	0.000273	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PIK3CA—obesity	2.82e-05	0.000273	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ADH1B—obesity	2.78e-05	0.000268	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—obesity	2.74e-05	0.000264	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PIK3CB—obesity	2.73e-05	0.000264	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MTOR—obesity	2.73e-05	0.000264	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACSL1—obesity	2.73e-05	0.000264	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PPARGC1B—obesity	2.73e-05	0.000264	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GPAM—obesity	2.73e-05	0.000264	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PCK1—obesity	2.65e-05	0.000257	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—HADH—obesity	2.65e-05	0.000257	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—FADS1—obesity	2.65e-05	0.000257	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—obesity	2.61e-05	0.000253	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACP5—obesity	2.58e-05	0.00025	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—obesity	2.55e-05	0.000246	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—AKT1—obesity	2.54e-05	0.000245	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—G6PD—obesity	2.52e-05	0.000243	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL6—obesity	2.5e-05	0.000241	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SREBF2—obesity	2.49e-05	0.00024	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—HK1—obesity	2.49e-05	0.00024	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—obesity	2.48e-05	0.00024	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LPA—obesity	2.4e-05	0.000232	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MMP9—obesity	2.38e-05	0.00023	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LPIN1—obesity	2.35e-05	0.000227	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MAPK8—obesity	2.31e-05	0.000223	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—obesity	2.31e-05	0.000223	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—AKT1—obesity	2.31e-05	0.000223	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—APOA5—obesity	2.3e-05	0.000222	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	2.24e-05	0.000216	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CLOCK—obesity	2.2e-05	0.000212	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC22A1—obesity	2.2e-05	0.000212	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	2.19e-05	0.000212	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	2.17e-05	0.00021	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	2.17e-05	0.000209	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SULT2A1—obesity	2.14e-05	0.000207	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GLP1R—obesity	2.14e-05	0.000207	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—STAT3—obesity	2.11e-05	0.000204	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DPYD—obesity	2.11e-05	0.000203	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PRKAR2B—obesity	2.03e-05	0.000196	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DCN—obesity	2.01e-05	0.000194	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.98e-05	0.000191	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MYC—obesity	1.96e-05	0.00019	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TGFB1—obesity	1.96e-05	0.000189	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CPT1A—obesity	1.96e-05	0.000189	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NAMPT—obesity	1.92e-05	0.000185	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	1.91e-05	0.000184	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LIPC—obesity	1.91e-05	0.000184	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GCK—obesity	1.91e-05	0.000184	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—APOC3—obesity	1.9e-05	0.000183	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	1.88e-05	0.000182	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CETP—obesity	1.84e-05	0.000178	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SDC1—obesity	1.82e-05	0.000176	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—AKR1C3—obesity	1.79e-05	0.000173	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SCARB1—obesity	1.76e-05	0.00017	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.74e-05	0.000168	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	1.72e-05	0.000166	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SREBF1—obesity	1.71e-05	0.000165	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PIK3CA—obesity	1.67e-05	0.000161	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GOT2—obesity	1.66e-05	0.000161	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.64e-05	0.000159	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—FASN—obesity	1.63e-05	0.000157	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—BCHE—obesity	1.62e-05	0.000157	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP2E1—obesity	1.56e-05	0.000151	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NQO1—obesity	1.55e-05	0.000149	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.51e-05	0.000146	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.5e-05	0.000145	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GCG—obesity	1.48e-05	0.000143	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC2A4—obesity	1.48e-05	0.000143	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL6—obesity	1.48e-05	0.000143	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYCS—obesity	1.46e-05	0.000141	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GGT1—obesity	1.44e-05	0.000139	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GOT1—obesity	1.44e-05	0.000139	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NCOA1—obesity	1.41e-05	0.000137	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—STK11—obesity	1.39e-05	0.000135	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP19A1—obesity	1.39e-05	0.000135	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—AKT1—obesity	1.36e-05	0.000132	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—COMT—obesity	1.3e-05	0.000125	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GNB3—obesity	1.28e-05	0.000124	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PPARGC1A—obesity	1.28e-05	0.000124	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—HMOX1—obesity	1.27e-05	0.000123	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GNAS—obesity	1.24e-05	0.00012	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—APOB—obesity	1.22e-05	0.000118	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LPL—obesity	1.16e-05	0.000112	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GPX1—obesity	1.14e-05	0.00011	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CD36—obesity	1.11e-05	0.000107	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MTHFR—obesity	1.05e-05	0.000101	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PPARA—obesity	1.03e-05	9.93e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—AGT—obesity	9.96e-06	9.62e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—APOE—obesity	9.76e-06	9.43e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CAV1—obesity	9.67e-06	9.34e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—APOA1—obesity	9.64e-06	9.32e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.23e-06	8.92e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIK3CG—obesity	8.8e-06	8.51e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PPARG—obesity	8.5e-06	8.21e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—POMC—obesity	8.38e-06	8.1e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—INS—obesity	8.33e-06	8.05e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIK3CD—obesity	7.74e-06	7.48e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ALB—obesity	7.64e-06	7.38e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIK3R1—obesity	7.31e-06	7.06e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NOS3—obesity	7.31e-06	7.06e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIK3CB—obesity	6.75e-06	6.52e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PTGS2—obesity	6.68e-06	6.46e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIK3CA—obesity	4.11e-06	3.97e-05	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—AKT1—obesity	3.36e-06	3.25e-05	CbGpPWpGaD
